Tomocube Inc (475960.KQ) stock: key figures, P/E, revenue and dividend

Health Care · South Korea

Price
28,350.00 KRW
Market cap
379.42 bn KRW
P/E (2025)
–
P/S (2025)
33.56
Dividend yield
0.00 %
Net margin
-42.54 %
Return on equity (ROE)
-12.40 %
Return on assets (ROA)
-11.59 %

Tomocube Inc financials

Fiscal year20242025
Revenue5.94 bn KRW11.31 bn KRW
Gross profit3.59 bn KRW7.44 bn KRW
Operating income-8.78 bn KRW-5.57 bn KRW
EBIT-8.24 bn KRW-4.74 bn KRW
Net income-8.30 bn KRW-4.81 bn KRW
Diluted EPS – continuing operations-636.32 KRW-359.40 KRW

Full history since 2021, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Tomocube Inc

Tomocube, Inc. engages in the manufacture and sale of optical devices and medical equipment. Its holotomography (HT) products include HT-X1 for live-cell imaging and analysis; and HT-2H for 3D live cell imaging. The company also offers TomoAnalysis, a 3D image visualization and analysis software. In addition, it provides accessories, such as HT-ready 96 well plates; TomoDish that is designed to accommodate both adherent and suspension cells; TomoChamber, a stage-top incubator designed for long-term live cell imaging; TomoPlate, an active vibration isolation system that enables users to capture images in a stable environment; and vessel holders, environmental controllers, and 3D controllers. The company was founded in 2015 and is headquartered in Daejeon, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.